|
HoLEP with MOSES technology has been demonstrated to:
- Provide excellent and durable clinical outcomes (PVR, Qmax, IPSS and QoL) with a reoperation* rate of only 0.7% at 10-year follow-up.1
- Transform BPH management, as it suits a majority of patients regardless of prostate size, anticoagulants therapy and age.2-5
- Result in successful same-day discharge of >90% of patients thanks to faster enucleation and hemostasis time.6,7
Compared with standard holmium, MOSES Technology can enable a tapered learning curve by providing better vision clarity and control during the procedure.7
*Reoperation as a result of recurrent obstruction from residual adenoma.
"Clear, measurable clinical value. With this new technology we have been successful in transitioning the majority of our HoLEP procedures to same day discharge home.”
Dr. Amy E. Krambeck, Northwestern Medical
The MOSES Technology BPH Bubble Allows Unique Optimisation for BPH Procedures
Shifting Paradigms in BPH Treatments
MOSES Technology with unique waveform optimised for BPH procedures.
